|
Dec 4
|
Roche to buy Carmot for up to $3.1bn as race for obesity drugs intensifies
|
|
Nov 28
|
Roivant’s Matt Gline on raising capital and biotech’s outlook for 2024
|
|
Nov 27
|
Roche expands hepatitis diagnostics portfolio to help clinicians diagnose and monitor patients with acute or chronic hepatitis B infection
|
|
Oct 2
|
Baudax's (BXRX) Hemophilia A Drug Gets FDA's Orphan Drug Tag
|
|
Oct 2
|
Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD
|
|
Oct 2
|
Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD
|
|
Sep 28
|
Ionis (IONS) Inks New Deal With Roche to Develop Novel RNA Drugs
|
|
Jul 21
|
CHMP recommends Roche’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)
|
|
Jul 20
|
New clinical and real-world data for Roche’s Vabysmo at ASRS reveal improved outcomes for people with two leading causes of vision loss
|
|
Jul 20
|
New Clinical and Real-World Data for Genentech’s Vabysmo at ASRS Reveal Improved Outcomes for People With Two Leading Causes of Vision Loss
|
|
Jul 19
|
Roche to showcase next-generation diagnostic solutions at the American Association of Clinical Chemistry 2023 Clinical Lab Expo
|
|
Jul 19
|
The Zacks Analyst Blog Highlights Roche, Fomento Economico Mexicano, Advanced Micro Devices, Union Pacific and Mondelez International
|
|
Jul 18
|
Why Novartis Stock Spiked Today
|
|
Jul 18
|
Q2 Earnings Scorecard and Analyst Reports for Roche, AMD & Others
|
|
Jul 18
|
Lilly's (LLY) Donanemab Slows Alzheimer's Disease Progression
|
|
Jul 17
|
2 Nasdaq Stocks That Could Soar This Week
|
|
Apr 26
|
Drug Heavyweights GSK, Roche Topple As Covid Weighs On Sales Growth
|
|
Apr 26
|
CHMP recommends EU approval of Roche’s fixed-duration Columvi (glofitamab) for people with relapsed or refractory diffuse large B-cell lymphoma
|
|
Apr 26
|
Roche's Q1 Highlights: Increased Uptake Of Eye Disease Drug Cushions Sales Decline
|
|
Apr 26
|
Roche (RHHBY) Q1 Revenues Decline on Lower COVID-19 Test Sales
|